yucca Reviews
Save up to $400 on your first order
Last updated: Sep 2, 2026
Medically reviewed by Francheska Capistrano, RMT, MPH · · How we review
Medically reviewed by Francheska Capistrano, RMT, MPH · Medical Content Reviewer
Medically reviewed on Reviewed · Written by Treatments Hub Research Team
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
The bottom line
Yucca delivers a clean, modern telehealth experience for patients seeking affordable GLP-1 weight loss treatment. While it lacks the coaching depth of some competitors, its streamlined process, transparent pricing, and licensed clinical oversight make it a compelling option for people who want effective treatment without complexity.
Yucca is a modern telehealth platform focused on making GLP-1 weight loss treatment simple and accessible. Their streamlined process connects patients with licensed clinicians who evaluate eligibility, prescribe medication, and provide ongoing support - all through a clean, easy-to-use online experience.
Key Features
- Fast online eligibility evaluation
- Licensed clinician consultations included
- GLP-1 medication prescribed and delivered
- Affordable, transparent monthly pricing
- Ongoing clinical support and check-ins
Treatment Options
- Compounded semaglutide
- Compounded tirzepatide
- Clinician-guided dosage adjustments
- Ongoing treatment monitoring
Pricing
Yucca offers straightforward monthly plans that include clinician consultations, GLP-1 medication, and home delivery. Pricing is transparent with no hidden fees or long-term contracts.
Pros
- Simple and fast onboarding process
- Affordable pricing compared to competitors
- Licensed clinicians oversee all care
- Clean, modern user experience
- No long-term contracts required
Cons
- Newer platform with limited brand recognition
- Fewer lifestyle support features
- Limited availability in some states
Who It's Best For
- People looking for affordable GLP-1 access
- Those who prefer a fast, simple onboarding process
- Anyone who values a modern, no-frills telehealth experience
Final Verdict
Yucca delivers a clean, modern telehealth experience for patients seeking affordable GLP-1 weight loss treatment. While it lacks the coaching depth of some competitors, its streamlined process, transparent pricing, and licensed clinical oversight make it a compelling option for people who want effective treatment without complexity.
yucca Review: FAQs
Is yucca legit?
Yucca is a modern telehealth platform focused on making GLP-1 weight loss treatment simple and accessible. Their streamlined process connects patients with licensed clinicians who evaluate eligibility, prescribe medication, and provide ongoing support - all through a clean, easy-to-use online experience.
How much does yucca cost?
Yucca offers straightforward monthly plans that include clinician consultations, GLP-1 medication, and home delivery. Pricing is transparent with no hidden fees or long-term contracts.
What treatments does yucca offer?
yucca offers Compounded semaglutide, Compounded tirzepatide, Clinician-guided dosage adjustments, Ongoing treatment monitoring.
Who is yucca best for?
yucca is best for People looking for affordable GLP-1 access; Those who prefer a fast, simple onboarding process; Anyone who values a modern, no-frills telehealth experience.
Is yucca worth it?
Yucca delivers a clean, modern telehealth experience for patients seeking affordable GLP-1 weight loss treatment. While it lacks the coaching depth of some competitors, its streamlined process, transparent pricing, and licensed clinical oversight make it a compelling option for people who want effective treatment without complexity.
Not sure if yucca is right for you?
Take our free quiz and get a personalized provider recommendation.
Find Your MatchRelated
Guides
Sources & methodology
We built this review of yucca from the provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.
Provider information
Pricing, plans, shipping and policies, checked against each provider's own site.
- yucca - pricing, plans & policies as published on its own site
Provider data checked September 2026
Customer & community feedback
Third-party signals shown on this page and in our full reviews: public Reddit discussions and independent YouTube reviews. We report what these sources say - we never fold them into our own scores.
Medical & regulatory references
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)
Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.
Medical disclaimer
This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.
Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.
Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)
